z-logo
Premium
6‐[ 123 I]Iodo‐2‐[[4‐(2‐methoxyphenyl) piperazin‐1‐yl]methyl]imidazo[1,2‐ a ]pyridine as potential SPECT agent for imaging dopamine D 4 receptor: synthesis and in vivo evaluation in a nonhuman primate
Author(s) -
Alagille David,
Koren Andrei O.,
Kudej Greg,
Staley Julie,
Cosgrove Kelly,
Seibyl John,
Tamagnan Gilles D.
Publication year - 2008
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1500
Subject(s) - chemistry , chloramine t , radioligand , methyl iodide , agonist , dopamine , pyridine , radiosynthesis , in vivo , dopamine agonist , stereochemistry , medicinal chemistry , radiochemistry , in vitro , receptor , medicine , biochemistry , organic chemistry , microbiology and biotechnology , biology
The dopamine D 4 receptor subtype has drawn considerable attention due to its potential implication in schizophrenia and erectile dysfunction. 6‐[ 123 I]Iodo‐2‐[[4‐(2‐methoxyphenyl)piperazin‐1‐yl]methyl]imidazo[1,2‐ a ]pyridine [ 123 I]‐1, a potent and selective new dopamine D 4 agonist, was synthesized by classical iododestannylation using sodium [ 123 I]iodide and chloramine‐T. Radiolabeling yield varied from 34 to 38% with a radiochemical purity exceeding 99%. Despite a good in vitro profile, in vivo evaluation of this radioligand in baboon showed no brain uptake after i.v. injection. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom